Filing Details
- Accession Number:
- 0001209191-19-003469
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-11 18:44:48
- Reporting Period:
- 2019-01-09
- Accepted Time:
- 2019-01-11 18:44:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
831547 | Spectrum Pharmaceuticals Inc | SPPI | Pharmaceutical Preparations (2834) | 930979187 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1574659 | W. Joseph Turgeon | 11500 S. Eastern Avenue Suite 240 Henderson NV 89052 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2019-01-09 | 133,434 | $0.00 | 449,943 | No | 4 | A | Direct | |
Common Stock, $0.001 Par Value | Disposition | 2019-01-11 | 36,311 | $10.87 | 413,632 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares of common stock reported herein as a result of the determination by the Compensation Committee that applicable performance criteria have been satisfied pursuant to the terms of Mr. Turgeon's award agreement.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with performance restricted stock units granted by the issuer.